Johnson & Johnson is collating its pantheon of medtech brands under a single banner, to further simplify the company’s ...

We believe that Johnson & Johnson stock (NYSE: JNJ) is currently a better pick than Procter & Gamble stock (NYSE: PG) as it appears to show more promise over the coming years. The decision to ...

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...

Johnson & Johnson (NYSE:JNJ) has extended a timeline to get more votes for its previously announced ~$6.5B bankruptcy deal to settle thousands of lawsuits alleging ovarian cancer risk linked to ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other stocks recommended by ChatGPT. ChatGPT has quickly become an essential tool for both ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other blue chip stocks. While economic data may be scarce, every data point gives a new angle ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Johnson & Johnson’s Imbruvica is among the drugs to be a part of the first round of drug price negotiation. Price Action: JNJ ...

Johnson & Johnson offers an annual dividend yield of 3.01%. How can investors exploit its dividend yield to pocket a regular $500 monthly? Avi Kapoor Metals in Tampons: FDA Initiates New Safety ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other cancer stocks. In 2022, the global oncology market was valued at approximately $203.42 ...

Johnson & Johnson JNJ said Tuesday the U.S. Food and Drug Administration has approved a combination treatment for a type of lung cancer that’s the first chemotherapy-free regimen. The FDA has ...